Xi Liang Song
Direktor/Vorstandsmitglied bei QINGDAO SENTURY TIRE CO., LTD.
Aktive Positionen von Xi Liang Song
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| QINGDAO SENTURY TIRE CO., LTD. | Direktor/Vorstandsmitglied | 18.11.2017 | - |
| Independent Dir/Board Member | 18.11.2017 | - | |
| YANTAI ZHENGHAI BIOTECHNOLOGY CO., LTD. | Direktor/Vorstandsmitglied | - | - |
| Independent Dir/Board Member | - | - | |
| Chinese Institute of Finance | Corporate Officer/Principal | - | - |
| Cost for Young & Mid-Career Professionals | Corporate Officer/Principal | - | - |
| Shandong Chamber of Accounting | Corporate Officer/Principal | - | - |
| Shandong University of Finance | Corporate Officer/Principal | - | - |
MabPlex International Co., Ltd.
 MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Direktor/Vorstandsmitglied | 01.01.2022 | - |
| Independent Dir/Board Member | 01.01.2022 | - |
Karriereverlauf von Xi Liang Song
Ehemalige bekannte Positionen von Xi Liang Song
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| WEIHAI HUADONG AUTOMATION CO., LTD | Direktor/Vorstandsmitglied | 30.06.2015 | 01.03.2021 |
| Independent Dir/Board Member | 30.06.2015 | 01.03.2021 | |
| SHANDONG SACRED SUN POWER SOURCES CO.,LTD | Direktor/Vorstandsmitglied | 30.12.2013 | 24.12.2019 |
| Independent Dir/Board Member | 30.12.2013 | 24.12.2019 | |
| ░░░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Xi Liang Song
| Shandong University of Finance & Economics | Undergraduate Degree |
| Tianjin University of Finance & Economics | Graduate Degree |
| Beijing Jiaotong University | Doctorate Degree |
Statistik
International
| China | 14 |
| 2 |
Operativ
| Director/Board Member | 7 |
| Independent Dir/Board Member | 7 |
| Corporate Officer/Principal | 4 |
Sektoral
| Consumer Services | 5 |
| Health Technology | 4 |
| Producer Manufacturing | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| SHANDONG SACRED SUN POWER SOURCES CO.,LTD | Producer Manufacturing |
| WEIHAI HUADONG AUTOMATION CO., LTD | Technology Services |
| SHANDONG ZHONGLU OCEANIC FISHERIES COMPANY LIMITED | Consumer Non-Durables |
| QINGDAO SENTURY TIRE CO., LTD. | Consumer Durables |
| YANTAI ZHENGHAI BIOTECHNOLOGY CO., LTD. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
| Chinese Institute of Finance | |
| Cost for Young & Mid-Career Professionals | |
| Shandong Chamber of Accounting | |
Shandong Weigao Blood Purification Products Co., Ltd.
 Shandong Weigao Blood Purification Products Co., Ltd. Medical SpecialtiesHealth Technology Shandong Weigao Blood Purification Products Co., Ltd. engages in providing blood purification products. It offers dialyzers, hemodialysis machines, bloodlines, and peritoneal dialysis solutions. Its end users include hospitals and dialysis centers. The company was founded on December 27, 2004 and is headquartered in Weihai, China. | Health Technology |
MabPlex International Co., Ltd.
MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Health Technology |
- Börse
- Insiders
- Xi Liang Song
- Erfahrung
